Herpes Stigma: the Origin
It wasn’t until the 1960′s that Herpes Simplex Virus was divided into Type 1 and Type 2, for medical/scientific purposes. Until then, there was just Herpes Simplex Virus. Unfortunately, this would later develop into the myth of “good herpes” and “bad herpes”.
(Sidenote: Oral & Genital Herpes have no specific type; either location can host either Type 1 or Type 2, either of which can also infect any other surface of the body)
The herpes stigma is a comparatively recent phenomenon and is the direct result of a Burroughs Wellcome pharmaceutical marketing campaign in the late 1970′s through mid 1980′s. Prior to the development of antiviral drugs, cold sores and genital herpes (both caused by either of the herpes simplex viruses) were only treated symptomatically – symptoms could be alleviated but not prevented (and obviously, the viruses could not be eradicated from the body; they still cannot). Neither condition was considered to be a significant medical problem – a standard medical textbook such as Obstetric and Gynecological Nursing by Rosemary E Bailey, 1978 edition, did not even bother mentioning herpes.
A 1975 study of “Psychological morbidity in a clinic for sexually-transmitted disease” (Richard Mayou, The London Hospital). In the Journal of Clinical Investigation, Pedro Cuatrecasas stated, “during the R&D of acyclovir (Zovirax), marketing [department of Burroughs Wellcome] insisted that there were ‘no markets’ for this compound. Most had hardly heard of genital herpes…” Thus marketing the medical condition – separating the ‘normal cold sore’ from the ‘stigmatized genital infection’ was to become the key to marketing the drug, a process now known as ‘disease mongering’.
In the USA, prescription drugs can be advertised directly to the public. The Burroughs Wellcome advertising campaign was designed to stimulate demand for Zovirax by raising patients’ concern about the social consequences of infection and emphasizing that the drug could reduce outbreaks and transmission. The campaign created the stigma which has clung to genital herpes ever since.
It is conjectured by much of the the HSV community that the reason for lack of the same level of stigma in many non-English speaking countries is that, in many languages, the word ‘herpes’ is used for ‘cold sores’ – that while Herpes Simplex was divided into 2 categories scientifically in the 1960′s, it was never divided socially and relabeled. Therefore, when a genital infection is labelled ‘herpes’, the link to cold sores is made. This makes it less likely that the patient will be alarmed by the diagnosis.
Another key indicator is that the stigma is far more stronger in the societies where the Burroughs Wellcome marketing/advertising campaigns actually occurred in the 1970′s & 1980′s.
- ^ British Journal of Venereal Disease 1975 ["http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1045113/pdf]
- ^ Journal of Clinical Investigation ["http://www.jci.org/articles/view/29999]
- ^ R Moynihan - see Selling sickness: the pharmaceutical industry and disease mongering. BMJ 2002
- ^ Time magazine August 1982 cover ["http://www.time.com/time/covers/0,16641,19820802,00.html]
- ^ Time magazine August 1982 “New Scarlet Letter” ["http://www.time.com/time/magazine/article/0,9171,1715020,00.html]
- ^ Time magazine August 1982 “Behaviour: Battling an Elusive Invader” ["http://www.time.com/time/magazine/article/0,9171,925609,00.html]